Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Vaccine, Inactivated
- Indication / Application:For the prevention of Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and H9 subtype Avian Influenza .
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Vaccine, Inactivated
Composition and Content
| Disease | Strain | Antigen Content | Optional Strain(s) |
|---|---|---|---|
| ND | La Sota | ≥ 108.5 EID50/0.1ml | La Sota + A-VII; Clone30 |
| IB | M41 | ≥ 106.5 EID50/0.1ml | QX; M41 + QX |
| EDS | EDS-76 | ≥ 1000 HAU/dose | - |
| AI(H9N2) | Clade 9.4.2.5 | ≥ 108.5 EID50/0.1ml | H9 (9.4.1a); H9 (9.4.1b) |
Indications
For the prevention of Newcastle disease (La Sota strain), infectious bronchitis (M41 strain), egg drop syndrome (EDS-76 strain), and avian influenza (H9N2 subtype, clade 9.4.2.5). The duration of immunity is 4 months.
Dosage and Administration
Administer subcutaneously in the neck to layers and breeders 2-3 weeks before the onset of lay at 0.5 mL per bird.
Adverse Reactions
Generally, no adverse reactions occur.
Specification
250 mL/bottle; 500 mL/bottle.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
A uniform milky-white emulsion.
Precautions
- 1. For use in healthy chicks only.
- 2. Shake thoroughly and allow the vaccine to reach room temperature before use.
- 3. Use this product within 24 hours after opening.
- 4. Do not freeze this product.
- 5. Do not use if foreign matter or emulsion separation is observed.
- 6. Dispose of used vaccine vials, equipment, and remaining vaccine safely.
- 7. This vaccine may be used with live Newcastle disease and infectious bronchitis vaccines to enhance cellular and mucosal immunity.
Features:
- 1. One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.
- 2. Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.
- 3. Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.
- 4. The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.
- 5.Classic antigen combination, essential and highly cost-effective for layer and breeding.